dr. emens on immune-related adverse events in ovarian cancer
Published 4 years ago • 73 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
-
0:50
dr. emens on the future of immunotherapy in ovarian cancer
-
3:05
treatment of emergent adverse events in ovarian cancer
-
1:02
dr. wenham on rationale for novel immunotherapy combos in ovarian cancer
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
3:05
immune adverse events of checkpoint inhibitors
-
1:11
dr. ledermann on the additive effects of olaparib and bevacizumab in ovarian cancer
-
7:26
emerging therapies in recurrent ovarian cancer
-
0:41
understand the adverse events of parp inhibitors
-
1:56
dr. sanaz memarzadeh on chemotherapy resistant tumor cells in ovarian cancer
-
1:19
dr. ledermann on phase iii ariel3 results in ovarian cancer
-
24:22
advances in immunology in ovarian cancer
-
0:48
immune checkpoint inhibitors in ovarian cancer
-
8:15
bevacizumab in ovarian cancer
-
3:15
unmet needs in ovarian cancer
-
2:11
dr. mirza on the rationale for the avanova trial in recurrent ovarian cancer
-
6:18
esmo 2014: inhibition of parp, angiogenesis and immune checkpoints for ovarian cancer management
-
1:57
ovarian cancer treatment - dr. neil rosenshein - mercy
-
0:53
the ova1 test and ovarian cancer| jonathan black md